Review Details Uneven Safety and Efficacy Evidence Across Janus Kinase Inhibitors
A comprehensive narrative review reveals that clinical safety profiles and therapeutic outcomes of Janus kinase inhibitors vary substantially across specific molecules, routes of administration, and patient populations.
Read moreDetails



















